EOFlow's insulin injection pump starts to be sold in UAE

The South Korean bio tech company is preparing to get approval in Saudi Arabia

Jeong Min Nam 1

2023-02-15 10:38:35 peux@hankyung.com

Bio & Pharma

South Korea's medical device maker EOFlow Co. started selling the wearable insulin pump EOPatch in the United Arab Emirates.

The company said on Tuesday that it is generating sales in the Middle East after signing a deal with local distribution partner GulfDrug. It has been six months since it received item permission for EOPatch from the UAE Ministry of Health and Prevention in August last year.

EOPatch is an insulin pump that automatically injects insulin once a diabetic patient enters a blood sugar value into the device.

Following the UAE, the company is also preparing for item approval in Saudi Arabia. "The Middle East and North Africa market with great growth potential, with 54 million diabetic patients in total," said a company official.

Write to Jeong Min Nam at peux@hankyung.com

S.Korea's Lunit supplies breast cancer imaging solution to UAE

South Korean companies ink $6.1 billion MOUs with UAE partners

Korea Ginseng Corp. intensifies marketing efforts in the UAE

(* comment hide *}